Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moayyedi

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|July 29, 2008
Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up studyA C Ford, D Forman, A G Bailey, et al.
European Journal of Gastroenterology & Hepatology|November 24, 1999
The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsiaP Moayyedi, A Zilles, M Clough, et al.
BMJ (Clinical Research Ed.)|September 15, 2000
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review GroupP Moayyedi, S Soo, J Deeks, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2010
Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agentsC Cameron, S V VAN Zanten, C Skedgel, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2012
The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up studyA C Ford, D Forman, A G Bailey, et al.
The American Journal of Gastroenterology|July 14, 2000
The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study GroupP Moayyedi, D Forman, D Braunholtz, et al.
Gastroenterology|October 26, 2001
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux diseaseP Moayyedi, C Bardhan, L Young, et al.
Gut|August 21, 2001
Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?M F Dixon, P M Neville, N P Mapstone, et al.
The Cochrane Database of Systematic Reviews|October 21, 2006
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingS Dorward, A Sreedharan, G I Leontiadis, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsiaP Moayyedi, S Soo, J Deeks, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|July 29, 2008
Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up studyA C Ford, D Forman, A G Bailey, et al.
European Journal of Gastroenterology & Hepatology|November 24, 1999
The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsiaP Moayyedi, A Zilles, M Clough, et al.
BMJ (Clinical Research Ed.)|September 15, 2000
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review GroupP Moayyedi, S Soo, J Deeks, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2010
Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agentsC Cameron, S V VAN Zanten, C Skedgel, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2012
The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up studyA C Ford, D Forman, A G Bailey, et al.
The American Journal of Gastroenterology|July 14, 2000
The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study GroupP Moayyedi, D Forman, D Braunholtz, et al.
Gastroenterology|October 26, 2001
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux diseaseP Moayyedi, C Bardhan, L Young, et al.
Gut|August 21, 2001
Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?M F Dixon, P M Neville, N P Mapstone, et al.
The Cochrane Database of Systematic Reviews|October 21, 2006
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingS Dorward, A Sreedharan, G I Leontiadis, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsiaP Moayyedi, S Soo, J Deeks, et al.
Pageof 12